DISCOVERY
Uncover breakthrough
innovations during the drug
discovery phase.
innovations during the drug
discovery phase.
Three Key Impacts in 2025: Fundraising, ICH E6(R3), and Policy
A Q&A featuring Tania Zieja, President of Halloran Consulting Group.
483 Issues to Sites – Indicators of Sponsor Oversight Effectiveness
A U.S. Food and Drug Administration (FDA) Form 483 is issued to a company’s management at ...
Clinical Development Considerations for Small Molecules and Recombinant Proteins
Navigating the complexities of Chemistry, Manufacturing, and Controls (CMC) within the ...
How, Why, and When to Apply for an Orphan Drug Application
This article is written by Hema Balasubramanian and Mamta Puri-Lechner. In the rapidly ...
Key Strategies for Development Stage Biotechs: Developing an Organization and the Talent Within
Watch “Key Strategies for Development Stage Biotechs: Developing an Organization and the ...
Catching Up with Consulting — DIA 2024 Insights
This article is based on opinions and perceptions from the DIA 2024 Global Annual ...
Generative AI-Driven Clinical Trials: Are We There Yet?
This article is based on the session titled, “Generative AI-Driven Clinical Trials: Myth ...
Clinical Trials in 2024 - Are We Making the Grade?
Clinical Trials in 2024 - Are We Making the Grade? This article is based on the session ...
The Upside of Artificial Intelligence on Medical Writing
The Upside of Artificial Intelligence on Medical Writing This article is based on the ...
Building Your Leadership Superpowers
Building Your Leadership Superpowers This article is based on the session titled, ...